TXG
10x Genomics, Inc.Healthcare · $11.5B market cap
Verdict
We can't put a fair value on TXG right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.
Business quality
1 of 5 clear the 10% bar. What are the Big Five?
Follow TXG
Track it on your watchlist and see the full analysis. Free.
Create a free accountInsider activity
Since Sep 1, 2026: no open-market purchases, 6 sales worth $4.2M and 1 other filing (stock awards, tax withholding and similar). Why purchases matter
Sales
Taich Adam
Chief Financial Officer · 2026-09-09
Sold
$898K
Taich Adam
Chief Financial Officer · 2026-09-09
Sold
$2.0M
Taich Adam
Chief Financial Officer · 2026-09-09
Sold
$77K
STUELPNAGEL JOHN R
director · 2026-09-03
Sold
$387K
STUELPNAGEL JOHN R
director · 2026-09-03
Sold
$423K
Show all 6 salesShow fewer
STUELPNAGEL JOHN R
director · 2026-09-03
Sold
$425K
Other filings
About 10x Genomics, Inc.
Headquartered in Pleasanton, California, 10x Genomics, Inc. (founded in 2012 and known as 10X Technologies, Inc. until November 2014) is a prominent life science technology company. The firm specializes in creating and distributing sophisticated instrumentation, essential consumables, and software designed for in-depth analysis of biological systems. Its market presence extends globally, covering North America…
Biotechnology
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works